Introduction

Biosecurity and national security involve legal measures designed to prevent the misuse, theft, unauthorised transfer and deliberate release of dangerous biological materials. Modern biotechnology offers significant benefits in medicine, agriculture, public health and scientific research, but certain discoveries may also create risks if misused. Biosecurity law therefore seeks to protect public health, national infrastructure, food security and legitimate scientific activity while preserving constitutional rights and research freedom.

The legal framework includes domestic legislation, international treaties, export controls, laboratory oversight, cybersecurity requirements and criminal law. Its central challenge is balancing scientific progress with public safety, privacy, transparency and governmental accountability.

International Legal Framework

1. Biological Weapons Convention, 1972

The Biological Weapons Convention (BWC) prohibits the development, production, acquisition, stockpiling, retention and transfer of biological agents and toxins of types and quantities that have no justification for prophylactic, protective or other peaceful purposes. It also prohibits weapons and delivery equipment designed to use such agents for hostile purposes.

Article IV requires states to adopt necessary national measures to prohibit and prevent prohibited activities within their jurisdiction or control. Article X recognises peaceful scientific cooperation and the exchange of biological materials and technology for legitimate purposes.

The Convention consequently distinguishes legitimate biotechnology research from activities intended for hostile purposes. However, it lacks a comprehensive verification system comparable to those established under some other arms-control treaties.

2. United Nations Security Council Resolution 1540 (2004)

Resolution 1540 requires states to refrain from supporting non-state actors seeking to develop, acquire, manufacture, possess, transport, transfer or use nuclear, chemical or biological weapons and their delivery systems. It requires appropriate domestic legal and regulatory measures, including controls over relevant materials and safeguards against illicit access.

The resolution connects biological security with counterterrorism, criminal enforcement and international cooperation. Its implementation must nevertheless remain consistent with applicable human-rights obligations and legitimate scientific research.

National Legal Framework

1. United States

The United States regulates certain high-risk biological agents and toxins through the Federal Select Agent Program, supported by federal public-health and agricultural legislation. The Public Health Security and Bioterrorism Preparedness and Response Act 2002 strengthened controls over specified biological agents, while the Agricultural Bioterrorism Protection Act 2002 addresses relevant agricultural threats.

The Public Health Service Act, including 42 U.S.C. § 262a, provides statutory authority for controls over designated agents and toxins, including security, training and containment requirements. Research oversight policies also address certain dual-use research of concern, where legitimate scientific work could generate information or capabilities that create significant security risks.

The United States framework combines enforceable legislation with administrative rules and research policies. The precise obligations depend on the biological material, institution, activity and applicable funding or regulatory requirements.

2. India

India's biosecurity framework includes the Biological Diversity Act 2002, the Environment (Protection) Act 1986, applicable rules concerning hazardous microorganisms and genetically engineered organisms, and criminal laws addressing relevant prohibited conduct.

The National Disaster Management Authority and public-health authorities also contribute to preparedness and emergency response. Export controls under the Foreign Trade (Development and Regulation) Act 1992 and the Special Chemicals, Organisms, Materials, Equipment and Technologies (SCOMET) framework may apply to specified biological materials, technologies and related items.

These measures address different legal objectives and should not be treated as one comprehensive biosecurity statute. Regulatory applicability depends on the activity and the particular material or technology involved.

Major Case Laws and Judicial Principles

1. United States v. Progressive, Inc., 467 F. Supp. 990 (W.D. Wis. 1979)

This case concerned an attempt by the United States government to prevent publication of information relating to hydrogen-bomb design on national-security grounds. The court initially granted a temporary restraining order, but the government later withdrew its request for an injunction and the case did not produce a final merits ruling establishing a general rule of secrecy.

Although it concerned nuclear rather than biological technology, the case illustrates the tension between national security, scientific information and freedom of publication.

Legal significance: Restrictions on scientific information raise important questions about statutory authority, public interest and freedom of expression. The case should not be treated as a direct precedent authorising restrictions on biotechnology research.

2. Maryland v. King, 569 U.S. 435 (2013)

The United States Supreme Court considered whether collecting DNA from certain people arrested for serious offences was a reasonable search under the Fourth Amendment. The Court upheld the challenged collection practice in the circumstances presented, treating DNA analysis as serving legitimate identification interests.

The decision demonstrates that biological information can have significant law-enforcement value, but collection and analysis remain subject to constitutional principles.

Legal significance: Governmental use of biological information must be evaluated in light of privacy, the purpose of collection and applicable legal safeguards. The judgment does not authorise unrestricted collection or use of genetic data.

3. Association for Molecular Pathology v. Myriad Genetics, Inc., 569 U.S. 576 (2013)

The United States Supreme Court held that naturally occurring DNA segments are not patent-eligible merely because they have been isolated, while synthetically created complementary DNA may be patent-eligible in the circumstances considered.

The dispute concerned patent eligibility rather than biosecurity. Nevertheless, it illustrates the importance of defining the legal boundaries of biotechnology innovation and ownership.

Legal significance: Intellectual-property rights and national-security restrictions serve different purposes. A patent does not automatically authorise every use of a biological invention or exempt its holder from biosafety, export-control or public-health regulation.

4. Diamond v. Chakrabarty, 447 U.S. 303 (1980)

The United States Supreme Court held that a genetically engineered microorganism could qualify as patentable subject matter under the relevant patent statute because it was human-made rather than a naturally occurring organism.

The decision helped establish the legal significance of engineered biological inventions. It did not determine whether particular organisms are safe, whether their use is permissible or whether they create national-security risks.

Legal significance: Patent eligibility must be distinguished from regulatory approval. Biotechnology inventions may qualify for intellectual-property protection while remaining subject to independent safety and security controls.

Dual-Use Research, Privacy and Accountability

Dual-use research presents a central governance challenge because knowledge produced for beneficial purposes may also be misapplied. Regulators should apply risk-based oversight, independent review, appropriate access controls and proportionate disclosure policies without automatically treating all advanced biotechnology research as dangerous.

Genetic and health information also requires protection against unauthorised access, discriminatory use and excessive surveillance. Security measures should have a clear legal basis, defined purposes, appropriate safeguards and avenues for review. International cooperation is particularly important when research materials, datasets and scientific personnel cross national borders.

Conclusion

Biosecurity and national security law seek to prevent biological threats while preserving peaceful research, public health and scientific innovation. The Biological Weapons Convention and UN Security Council Resolution 1540 provide important international obligations, while national legislation establishes specific controls and enforcement mechanisms. United States v. Progressive, Maryland v. King, Association for Molecular Pathology v. Myriad Genetics and Diamond v. Chakrabarty offer relevant but limited judicial principles concerning security-sensitive information, biological data and biotechnology ownership. Effective governance ultimately requires proportionate regulation, scientific accountability, international cooperation and respect for fundamental rights.